The use of erythromycin and colistin-loaded cement in total knee arthroplasty does not reduce the incidence of infection : A prospective randomized study in 3000 knees

Journal of Bone and Joint Surgery

Volumn 95, Issue 9, 2013, Pages 769-774

  Hinarejos, Pedro ^a   Guirro, Pau ^a   Leal, Joan ^a   Montserrat, Ferran ^a   Pelfort, Xavier ^a   Sorli, M L ^a   Horcajada, J P ^a   Puig, Lluis ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC BONE CEMENT; CEFAZOLIN; COLISTIN; ERYTHROMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BONE CEMENT;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE CEMENT DEVICE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPERATION DURATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; CONTROLLED CLINICAL TRIAL; INCIDENCE; INFECTION; KNEE ARTHROPLASTY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BONE CEMENTS; COLISTIN; ERYTHROMYCIN; FEMALE; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS;

MLCS; MLOWN;

EID: 84879295332     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00901     Document Type: Article

References (38)

1. Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicin- impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am. 1978 Dec;60(8):1059-64
2. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br. 1997 Jul;79(4):590-5
3. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand. 2003 Dec;74(6):644-51
4. Dale H, Hallan G, Hallan G, Espehaug B, Havelin LI, Engesaeter LB. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop. 2009 Dec;80(6):639-45
5. Chiu FY, Chen CM, Lin CFJ, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am. 2002 May;84-A(5):759-62
6. Gandhi R, Razak F, Pathy R, Davey JR, Syed K, Mahomed NN. Antibiotic bone cement and the incidence of deep infection after total knee arthroplasty. J Arthroplasty 2009 Oct;24(7):1015-8
7. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections,1992: amodification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8
8. Heck D, Rosenberg A, Schink-Ascani M, Garbus S, Kiewitt T. Use of antibioticimpregnated cement during hip and knee arthroplasty in the United States. J Arthroplasty 1995 Aug;10(4):470-5
9. Malik MH, Chougle A, Pradhan N, Gambhir AK, Porter ML. Primary total knee replacement: a comparison of a nationally agreed guide to best practice and current surgical technique as determined by the North West Regional Arthroplasty Register Ann R Coll Surg Engl. 2005 Mar;87(2):117-22
10. Robertsson O, Knutson K, Lewold S, Lidgren L. The Swedish Knee Arthroplasty Register 1975-1997: an update with special emphasis on 41,223 knees operated on in 1988-1997. Acta Orthop Scand. 2001 Oct;72(5):503-13
11. Fish DN, Hoffman HM, Danziger LH. Antibiotic-impregnated cement use in U.S hospitals. Am J Hosp Pharm. 1992 Oct;49(10):2469-74
12. Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am. 2006 Nov;88(11):2487-500
13. Bourne RB. Prophylactic use of antibiotic bone cement: an emerging standard- in the affirmative. J Arthroplasty. 2004 Jun;19(4)(Suppl 1):69-72
14. Cummins JS, Tomek IM, Kantor SR, Furnes O, Engesaeter LB, Finlayson SR Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty. J Bone Joint Surg Am. 2009 Mar 1;91(3):634-41
15. Espehaug B, Furnes O, Havelin LI, Engesaeter LB, Vollset SE. The type of cement and failure of total hip replacements. J Bone Joint Surg Br. 2002 Aug;84(6):832-8
16. Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI. Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56,275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop. 2006 Jun;77(3):351-8
17. Josefsson G, Gudmundsson G, Kolmert L, Wijkström S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clin Orthop Relat Res. 1990 Apr;(253):173-8
18. Josefsson G, Kolmert L. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1,688 hips. Clin Orthop Relat Res. 1993 Jul;(292):210-4
19. Jämsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am 2009 Jan;91(1):38-47
20. Australian Orthopaedic Association. National Joint Replacement Registry 2011 Annual Report. http://www.dmac.adelaide.edu.au/aoanjrr/documents/ AnnualReports2011/CementinHipandKneeArthroplasty2011.pdf. Accessed 2012 Mar 28
21. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study. J Bone Joint Surg Br. 2001 Jul;83(5):691-5
22. Liu HT, Chiu FY, Chen CM, Chen TH. The combination of systemic antibiotics and antibiotics impregnated cement in primary total knee arthroplasty in patients of rheumatoid arthritis-evaluation of 60 knees. J Chin Med Assoc. 2003 Sep;66(9):533-6
23. Namba RS, Chen Y, Paxton EW, Slipchenko T, Fithian DC. Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty. J Arthroplasty 2009 Sep;24(6)(Suppl):44-7
24. Scott CP, Higham PA, Dumbleton JH. Effectiveness of bone cement containing tobramycin. An in vitro susceptibility study of 99 organisms found in infected joint arthroplasty. J Bone Joint Surg Br. 1999 May;81(3):440-3
25. Rosenthal AL, Rovell JM, Girard AE. Polyacrylic bone cement containing erythromycin and colistin. I. In vitro bacteriological activity and diffusion properties of erythromycin, colistin and erythromycin/colistin comibination. J Int Med Res 1976;4(5):296-304
26. Ruzaimi MY, Shahril Y, Masbah O, Salasawati H. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis. Med J Malaysia. 2006 Feb;61(Suppl A):21-6
27. Davies JP, O'Connor DO, Burke DW, Harris WH. Influence of antibiotic impregnation on the fatigue life of Simplex P and Palacos R acrylic bone cements, with and without centrifugation. J Biomed Mater Res. 1989 Apr;23(4):379-97
28. Garvin KL, Konigsberg BS. Infection following total knee arthroplasty: prevention and management. J Bone Joint Surg Am. 2011 Jun 15;93(12):1167-75
29. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010 Jan;468(1):52-6
30. Walenkamp G. Surveillance of surgical-site infections in orthopedics. Acta Orthop Scand. 2003 Apr;74(2):172-4
31. Mraovic B, Suh D, Jacovides C, Parvizi J. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol. 2011 Mar;5(2):412-8
32. Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br 2010 Aug;92(8):1128-33
33. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009 Sep; 24(6)(Suppl):84-8
34. Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res. 2009 Jun;467(6):1577-81
35. Suleiman LI, Ortega G, Ong'uti SK, Gonzalez DO, Tran DD, Onyike A, Turner PL, Fullum TM. Does BMI affect perioperative complications following total knee and hip arthroplasty? J Surg Res. 2012 May 1;174(1):7-11
36. Jämsen E, Nevalainen P, Kalliovalkama J, Moilanen T. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. 2010 Jun;21(3): 196-201
37. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008 Jul;466(7):1710-5
38. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007 Aug 16;357(7):654-63